Why insider trading matters?

If management teams do not own any relevant stakes in the companies they guide, they may not be focused on creating wealth for shareholders to the same degree, compared to those that see their personal wealth increase when share prices rise.

- Klaus Gugler, Economist
Summit Therapeutics Inc. (SMMT)
Sector: Healthcare; Industry: Biotechnology

Summit Therapeutics plc, a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States, Latin America, and Europe. It conducts clinical programs focusing on the Clostridium difficile infection (CDI). The company was formerly known as Summit Corporation plc and changed its name to Summit Therapeutics plc in February 2015. Summit Therapeutics plc was founded in 2003 and is based in Abingdon, the United Kingdom.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-05-12 DUGGAN ROBERT W Chief Executive Officer Buy 11,365,921 $5.24 $59,557,426 No
2021-05-12 Zanganeh Maky Chief Operating Officer Buy 389,077 $5.24 $2,038,763 No
2020-11-30 Powell David Jonathan Chief Scientific Officer Sell 43,282 $4.41 $190,694 Yes
2020-11-25 Powell David Jonathan Chief Scientific Officer Sell 30,431 $4.30 $130,770 Yes
2020-11-06 DUGGAN ROBERT W Chief Executive Officer Buy 14,071,856 $3.34 $46,999,999 No

Insider Smart

Altimmune, Inc. (ALT) - Venrock Healthcare Capital Partners III, L.P., 10%-owner of ALT bought 1.3M shares in late May then added another 1.5M shares in June with an averaged ~$8 per share. 10 days after the accumulation, ALT price jumped to $10.

Insider Smart

Planet Fitness, Inc (PLNT) - Our position in PLNT is also inspired by insider trading, if insiders are comfortable and confident buying around $50, it is an easy hold if you can pick it up at an even lower price. Our avg cost of the position is ~$40 and is now with 50% profit.